The chemical industry, which converts raw materials into chemicals used as essential components in everyday items, supports 25% of the US GDP and is a $486 billion market. The US is the second-largest global chemical producer (responsible for 13% of the world's production), and 96% of US-made goods rely on chemical sector products in their manufacturing. The chemical industry is also essential for many of today's necessities, such as safe drinking water, food, energy, medicine, and more. Hydrogen peroxide, for example, is used in the production of bleach, rocket fuel, foam rubber, medicinal products, organic chemicals, and cleaning agents found in toothpaste and household cleaners.
Chemicals can take a long time to break down naturally in the environment, but new technologies have emerged that can destroy them in a matter of seconds. Researchers are racing to identify commercially viable methods that could be used to eliminate contamination in identified hot spots across the US. Meanwhile, dozens of startups are pursuing technologies for the removal of per and polyfluorinated substances (PFAS), most of which remain in the lab and have yet to be brought to market at scale. For example, Aquagga is a cleantech hardware startup developing technology to break down and destroy PFAS. The company traces its roots to research at the University of Washington and the University of Alaska.
Another way of dealing with the carbon footprint of chemicals is to rethink how we make chemicals in the first place. For example, the startup Solugen utilizes patented bioforge technology which combines synthetic biology, metal catalyst engineering, and modular plant design to create chemicals from bio-based feedstocks. This process intends to replace traditional chemical production, which relies on fossil fuels, with environmentally friendly, faster, cheaper, and more efficient alternatives. Solugen modifies corn syrup with genetically engineered enzymes to create high-performance substitutes for everyday chemicals. Check out our full memo on Solugen here.
Important Disclosures
This material has been distributed solely for informational and educational purposes only and is not a solicitation or an offer to buy any security or to participate in any trading strategy. All material presented is compiled from sources believed to be reliable, but accuracy, adequacy, or completeness cannot be guaranteed, and Contrary LLC (Contrary LLC, together with its affiliates, “Contrary”) makes no representation as to its accuracy, adequacy, or completeness.
The information herein is based on Contrary beliefs, as well as certain assumptions regarding future events based on information available to Contrary on a formal and informal basis as of the date of this publication. The material may include projections or other forward-looking statements regarding future events, targets or expectations. Past performance of a company is no guarantee of future results. There is no guarantee that any opinions, forecasts, projections, risk assumptions, or commentary discussed herein will be realized. Actual experience may not reflect all of these opinions, forecasts, projections, risk assumptions, or commentary.
Contrary shall have no responsibility for: (i) determining that any opinions, forecasts, projections, risk assumptions, or commentary discussed herein is suitable for any particular reader; (ii) monitoring whether any opinions, forecasts, projections, risk assumptions, or commentary discussed herein continues to be suitable for any reader; or (iii) tailoring any opinions, forecasts, projections, risk assumptions, or commentary discussed herein to any particular reader’s objectives, guidelines, or restrictions. Receipt of this material does not, by itself, imply that Contrary has an advisory agreement, oral or otherwise, with any reader.
Contrary is registered with the Securities and Exchange Commission as an investment adviser under the Investment Advisers Act of 1940. The registration of Contrary in no way implies a certain level of skill or expertise or that the SEC has endorsed Contrary. Investment decisions for Contrary clients are made by Contrary. Please note that, although Contrary manages assets on behalf of Contrary clients, Contrary clients may take any position (whether positive or negative) with respect to the company described in this material. The information provided in this material does not represent any investment strategy that Contrary manages on behalf of, or recommends to, its clients.
Different types of investments involve varying degrees of risk, and there can be no assurance that the future performance of any specific investment, investment strategy, company or product made reference to directly or indirectly in this material, will be profitable, equal any corresponding indicated performance level(s), or be suitable for your portfolio. Due to rapidly changing market conditions and the complexity of investment decisions, supplemental information and other sources may be required to make informed investment decisions based on your individual investment objectives and suitability specifications. All expressions of opinions are subject to change without notice. Investors should seek financial advice regarding the appropriateness of investing in any security of the company discussed in this presentation.
Please see www.contrary.com/legal for additional important information.
